These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 10217333)

  • 21. Therapeutic drug monitoring of phenytoin in critically ill patients.
    von Winckelmann SL; Spriet I; Willems L
    Pharmacotherapy; 2008 Nov; 28(11):1391-400. PubMed ID: 18956999
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prediction of free phenytoin levels based on [total phenytoin]/[albumin] ratios. Potential errors with hypoalbuminemia.
    Dasgupta A; Dennen DA; Dean R; McLawhon RW
    Am J Clin Pathol; 1991 Feb; 95(2):253-6. PubMed ID: 1992618
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of unbound phenytoin concentrations in neurointensive care unit patients using a revised Winter-Tozer equation.
    Kane SP; Bress AP; Tesoro EP
    Ann Pharmacother; 2013 May; 47(5):628-36. PubMed ID: 23606554
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elevated free phenytoin and free valproic acid concentrations in sera of patients infected with human immunodeficiency virus.
    Dasgupta A; McLemore JL
    Ther Drug Monit; 1998 Feb; 20(1):63-7. PubMed ID: 9485557
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical significance of correcting the serum level of phenytoin according to the albuminaemia in hospitalized patients and outpatients].
    Hermida-Ameijeiras J; Montero-Furelos C; Tutor-Valcarce JC
    Rev Neurol; 2003 Nov 16-30; 37(10):909-12. PubMed ID: 14634917
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of phenytoin drug concentration for evaluation of clinical response, uncontrolled seizures and toxicity.
    Shaikh AS; Li Y; Cao L; Guo R
    Pak J Pharm Sci; 2018 Jul; 31(4(Special)):1697-1700. PubMed ID: 30203765
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Accuracy of two equations in determining normalized phenytoin concentrations.
    Mauro LS; Mauro VF; Bachmann KA; Higgins JT
    DICP; 1989 Jan; 23(1):64-8. PubMed ID: 2718487
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nonlinear protein binding of phenytoin in clinical practice: Development and validation of a mechanistic prediction model.
    Ter Heine R; Kane SP; Huitema ADR; Krasowski MD; van Maarseveen EM
    Br J Clin Pharmacol; 2019 Oct; 85(10):2360-2368. PubMed ID: 31269540
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Free phenytoin toxicity.
    Imam SH; Landry K; Kaul V; Gambhir H; John D; Kloss B
    Am J Emerg Med; 2014 Oct; 32(10):1301.e3-4. PubMed ID: 24768668
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetic interaction in rabbits between a new anticonvulsant, DL-3-hydroxy-3-ethyl-3-phenylpropionamide, and phenytoin.
    Medina L; García L; Pérez R; Fernández A; Jung H
    J Pharm Pharmacol; 1998 Dec; 50(12):1393-6. PubMed ID: 10052855
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Elevated free fosphenytoin concentrations in uremic sera: uremic toxins hippuric acid and indoxyl sulfate do not account for the impaired protein binding of fosphenytoin.
    Dasgupta A; Havlik D
    Ther Drug Monit; 1998 Dec; 20(6):658-62. PubMed ID: 9853983
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Temperature dependence of phenytoin-protein binding in serum: effects of uremia and hypoalbuminemia.
    Allison TB; Comstock TJ
    Ther Drug Monit; 1988; 10(4):376-81. PubMed ID: 3201522
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Optimization of phenytoin therapy in adults with epilepsy in the Western Cape, South Africa.
    Valodia PN; Seymour MA; Kies BM; Folb PI
    J Clin Pharm Ther; 1999 Oct; 24(5):381-5. PubMed ID: 10583702
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Utility of free level monitoring of antiepileptic drugs.
    Levy RH; Schmidt D
    Epilepsia; 1985; 26(3):199-205. PubMed ID: 3924585
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation of free phenytoin to serum albumin in cancer patients.
    Umstead GS; Neumann KH
    DICP; 1990 Oct; 24(10):923-6. PubMed ID: 2244404
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Phenytoin].
    Furuno K; Kawasaki H; Gomita Y
    Nihon Rinsho; 1995 Feb; 53 Su Pt 1():924-7. PubMed ID: 8753589
    [No Abstract]   [Full Text] [Related]  

  • 37. Pharmacokinetic considerations in phenytoin pharmacotherapy: preventing overdoses and underdoses.
    Profeta LM; Bradbury K; Mehl B
    Mt Sinai J Med; 1995 Sep; 62(4):312-4. PubMed ID: 7565857
    [No Abstract]   [Full Text] [Related]  

  • 38. Binding of fosphenytoin, phosphate ester pro drug of phenytoin, to human serum proteins and competitive binding with carbamazepine, diazepam, phenobarbital, phenylbutazone, phenytoin, valproic acid or warfarin.
    Lai CM; Moore P; Quon CY
    Res Commun Mol Pathol Pharmacol; 1995 Apr; 88(1):51-62. PubMed ID: 7620838
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interactions of serum albumin, valproic acid and carbamazepine with the pharmacokinetics of phenytoin in cancer patients.
    Joerger M; Huitema AD; Boogerd W; van der Sande JJ; Schellens JH; Beijnen JH
    Basic Clin Pharmacol Toxicol; 2006 Aug; 99(2):133-40. PubMed ID: 16918714
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Severe phenytoin intoxication in patients with hypoalbuminaemia].
    Kemper EM; van Kan HJ; Speelman P; de Gans K; Beijnen JH; Schellens JH
    Ned Tijdschr Geneeskd; 2007 Jan; 151(2):138-41. PubMed ID: 17315493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.